Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1766
Title: Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance.
Author: Lindsay, J.
Othman, J.
Kerridge, I.
Fay, K.
Stevenson, W.
Arthur, C.
Chen, S.
Kong, David C. M.
Pergam, S.
Liu, C.
Slavin, M.
Greenwood, M.
Issue Date: 2021
Publication Title: Transplant Infectious Disease
Volume: 23
Issue: 3
Start Page: e13548
Abstract: Abstract Background: Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic hematopoietic cell transplant (alloHCT). Method: We analyzed 159 alloHCT recipients with 4409 quantitative CMV viral loads to determine pre-transplant predictors of CMV reactivation, clinically significant CMV infection (cs-CMVi, defined as CMV viral load >1000 IU/mL), CMV disease, kinetics of spontaneous clearance of CMV, and survival using a standardized pre-emptive therapy approach to identify at-risk groups to target prevention strategies. Results: Cs-CMVi was most common in D-/R+ unrelated donor transplants (URD). Spontaneous CMV clearance occurred in 26% of patients who reached a viral load of 56-137 IU/mL, 6% at 138-250 IU/mL and in one patient >250 IU/mL. Median time between the first CMV reactivation (>56 IU/mL) and a viral load >250 IU/mL was 13 days, whereas the time from the first viral load >250 IU/mL to reach a vial load >1000 IU/mL was 4 days. Cs-CMVi was associated with a significant increase in non-relapse mortality (NRM) on multivariate analysis. Conclusions: Overall, this study indicates that D-/R+ URD recipients are at high-risk for cs-CMVi- and CMV-related mortality, and are potential candidates for targeted CMV prophylaxis. Spontaneous clearance of CMV beyond a viral load of 250 IU/mL is uncommon, suggesting that this could be used as an appropriate threshold to initiate pre-emptive therapy.
URI: http://hdl.handle.net/11054/1766
DOI: https://doi.org/10.1111/tid.13548
Internal ID Number: 01720
Health Subject: CYTOMEGALOVIRUS
HEMATOPOIETIC CELL TRANSPLANTATION
PRE-EMPTIVE THERAPY
VIREMIA
Type: Journal Article
Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.